Kadimastem Ltd (KMSTF)
USD 0.64
(-90.0%)
USD 0.64
(-90.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -3.3 Million USD | 48.77% |
| 2022 | -6.45 Million USD | 23.65% |
| 2021 | -8.45 Million USD | -25.06% |
| 2020 | -6.76 Million USD | 6.9% |
| 2019 | -7.26 Million USD | -13.23% |
| 2018 | -6.41 Million ILS | -3.92% |
| 2017 | -6.17 Million ILS | -18.94% |
| 2016 | -5.18 Million ILS | 69.59% |
| 2015 | -17.06 Million ILS | -12.33% |
| 2014 | -15.19 Million ILS | -20.43% |
| 2013 | -12.61 Million ILS | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 Q2 | -1.85 Million USD | 0.0% |
| 2023 Q4 | -1.4 Million USD | 0.0% |
| 2023 FY | -3.3 Million USD | 48.77% |
| 2022 FY | -6.45 Million USD | 23.65% |
| 2022 Q2 | -3.54 Million USD | 0.0% |
| 2022 Q4 | -2.93 Million USD | 0.0% |
| 2021 Q2 | -4.17 Million USD | 0.0% |
| 2021 FY | -8.45 Million USD | -25.06% |
| 2021 Q4 | -4.07 Million USD | 0.0% |
| 2020 Q2 | -3.56 Million ILS | 45.03% |
| 2020 Q1 | -6.48 Million ILS | -75.74% |
| 2020 Q4 | -2.92 Million USD | 0.0% |
| 2020 FY | -6.76 Million USD | 6.9% |
| 2019 FY | -7.26 Million USD | -13.23% |
| 2019 Q4 | -3.68 Million USD | 0.0% |
| 2019 Q2 | -3.46 Million USD | 0.0% |
| 2018 FY | -6.41 Million ILS | -3.92% |
| 2017 FY | -6.17 Million ILS | -18.94% |
| 2016 FY | -5.18 Million ILS | 69.59% |
| 2015 FY | -17.06 Million ILS | -12.33% |
| 2014 FY | -15.19 Million ILS | -20.43% |
| 2013 FY | -12.61 Million ILS | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | -1.33 Million USD | -147.665% |
| Arch Therapeutics, Inc. | -6.98 Million USD | 52.635% |
| Evofem Biosciences, Inc. | 52.97 Million USD | 106.243% |
| Nascent Biotech, Inc. | -2.08 Million USD | -58.424% |
| Rebus Holdings, Inc. | -1.02 Million USD | -224.255% |
| Santhera Pharmaceuticals Holding AG | 65.13 Million USD | 105.078% |
| Qrons Inc. | -789.34 Thousand USD | -319.004% |
| Adynxx, Inc. | - USD | Infinity% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -422.986% |
| Northwest Biotherapeutics, Inc. | -62.59 Million USD | 94.717% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -696.045% |
| Skye Bioscience, Inc. | -37.64 Million USD | 91.214% |
| Eiger BioPharmaceuticals, Inc. | -74.96 Million USD | 95.588% |
| Nanobac Pharmaceuticals, Incorporated | -6.57 Million USD | 49.706% |
| Institute of Biomedical Research Corp. | -273.4 Thousand USD | -1109.72% |
| SQZ Biotechnologies Company | -79.46 Million USD | 95.838% |
| Intellipharmaceutics International Inc. | -2.89 Million USD | -14.348% |
| Propanc Biopharma, Inc. | -1.82 Million USD | -81.672% |
| Mesoblast Limited | -87.95 Million USD | 96.24% |
| Marizyme, Inc. | -65.34 Million USD | 94.939% |
| Genus plc | 7.9 Million USD | 141.866% |
| VioQuest Pharmaceuticals, Inc. | -10.89 Million USD | 69.634% |
| Pharming Group N.V. | -10.54 Million USD | 68.644% |
| Therapeutic Solutions International, Inc. | -2.16 Million USD | -52.428% |
| CNBX Pharmaceuticals Inc. | -3.71 Million USD | 10.857% |
| Nymox Pharmaceutical Corporation | -8.84 Million USD | 62.603% |
| ContraFect Corporation | -65.15 Million USD | 94.924% |
| PsyBio Therapeutics Corp. | -4.88 Million USD | 32.31% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.72 Million USD | -91.461% |
| IMV Inc. | -36.48 Million USD | 90.935% |
| AXIM Biotechnologies, Inc. | -8.05 Million USD | 58.964% |
| MultiCell Technologies, Inc. | -380.07 USD | -870107.593% |
| ONE Bio Corp. | 8.67 Million USD | 138.119% |
| Accustem Sciences Inc. | -3.74 Million USD | 11.718% |
| RVL Pharmaceuticals plc | -51.69 Million USD | 93.602% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | -1.26 Million USD | -161.014% |
| Q BioMed Inc. | -2.05 Million USD | -61.172% |
| Emmaus Life Sciences, Inc. | -3.73 Million USD | 11.401% |
| Mosaic ImmunoEngineering Inc. | -2.38 Million USD | -38.916% |
| Biomind Labs Inc. | -1.21 Million USD | -172.366% |
| American Oriental Bioengineering, Inc. | -59.72 Million USD | 94.462% |
| Provectus Biopharmaceuticals, Inc. | -3.1 Million USD | -6.629% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | -7.9 Million USD | 58.151% |
| GlobeStar Therapeutics Corporation | -1.94 Million USD | -69.676% |
| THC Farmaceuticals, Inc. | -14.97 Thousand USD | -21984.655% |
| Acro Biomedical Co., Ltd. | -15.87 Million USD | 79.161% |
| Curative Biotechnology, Inc. | -5.81 Million USD | 43.145% |
| GB Sciences, Inc. | -1.36 Million USD | -142.892% |
| Alpha Cognition Inc. | -13.77 Million USD | 75.986% |
| HST Global, Inc. | -146.21 Thousand USD | -2162.087% |
| CSL Limited | 2.64 Billion USD | 100.125% |
| Wesana Health Holdings Inc. | -1.75 Million USD | -88.48% |
| Halberd Corporation | -79.67 Thousand USD | -4051.059% |
| Enzolytics Inc. | -2.17 Million USD | -51.936% |
| Agentix Corp. | -1.37 Million USD | -140.676% |
| Resverlogix Corp. | -3.61 Million USD | 8.382% |
| Nuo Therapeutics, Inc. | -3.17 Million USD | -4.287% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -295.05 Million USD | 98.879% |
| Enzon Pharmaceuticals, Inc. | 98 Thousand USD | 3474.896% |
| Endonovo Therapeutics, Inc. | 6.92 Million USD | 147.763% |
| RespireRx Pharmaceuticals Inc. | -3.97 Million USD | 16.753% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.02 Million USD | -9.294% |
| AVAX Technologies, Inc. | -6.41 Million USD | 48.432% |
| Zenith Capital Corp. | -10.59 Million USD | 68.786% |
| Genscript Biotech Corporation | -95.47 Million USD | 96.536% |
| Ember Therapeutics, Inc. | -23.24 Thousand USD | -14130.264% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -4.14 Million USD | 20.226% |
| WPD Pharmaceuticals Inc. | -60.44 Thousand USD | -5372.145% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -64.948% |
| Helix BioMedix, Inc. | -1.05 Million USD | -213.184% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -3.81 Million USD | 13.396% |
| BioStem Technologies, Inc. | -8.48 Million USD | 61.011% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -441.36 Thousand USD | -649.35% |
| LadRx Corporation | 400.44 Thousand USD | 925.935% |
| Cell Source, Inc. | -5.32 Million USD | 37.845% |
| Regen BioPharma, Inc. | 1.02 Million USD | 423.143% |
| Regen BioPharma, Inc. | 1.02 Million USD | 423.143% |
| NovAccess Global Inc. | -4.76 Million USD | 30.651% |
| Affymax, Inc. | -14.42 Million USD | 77.07% |
| Itoco Inc. | -1.86 Million USD | -76.961% |
| Rasna Therapeutics, Inc. | -4.44 Million USD | 25.552% |
| Pathfinder Cell Therapy, Inc. | -1.66 Million USD | -98.166% |
| Mobile Lads Corp. | -2.26 Million USD | -46.132% |
| CytoDyn Inc. | -49.84 Million USD | 93.364% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.03 Thousand USD | -4084.832% |
| NanoSphere Health Sciences Inc. | -228.12 Thousand USD | -1349.806% |
| Alseres Pharmaceuticals, Inc. | -941.52 Thousand USD | -251.279% |
| SYBLEU INC | -180.3 Thousand USD | -1734.345% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.61 Million USD | -105.08% |
| International Stem Cell Corporation | -131 Thousand USD | -2424.731% |
| Bioxytran, Inc. | -4.28 Million USD | 22.724% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -54.27 Thousand USD | -5994.115% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.53 Million USD | -30.714% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -48.07 Million USD | 93.12% |
| Adhera Therapeutics, Inc. | -2.11 Million USD | -56.452% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -780.88 Thousand USD | -323.544% |
| Innovation Pharmaceuticals Inc. | -3.16 Million USD | -4.4% |
| Neutra Corp. | -233.46 Thousand USD | -1316.657% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | 83.7% |
| PureTech Health plc | -65.69 Million USD | 94.966% |
| Coeptis Therapeutics, Inc. | -21.26 Million USD | 84.448% |
| IXICO plc | -1.17 Million USD | -180.764% |
| IntelGenx Technologies Corp. | -9.92 Million USD | 66.683% |
| Gelesis Holdings, Inc. | -57.12 Million USD | 94.211% |
| CSL Limited | 2.64 Billion USD | 100.125% |
| Cellectis S.A. | -103.17 Million USD | 96.794% |